Since both genes are co-located on chromosome 2 q33.2, are members of the CD28 immune checkpoint receptor family, are co-expressed in melanomas from the TCGA cohort, we expected co-expression of ICOS and CTLA4 in melanoma cell lines as well. The gene discussed is CTLA4; the disease is melanoma.